Implanted radiation device cuts brain tumor recurrence: 5 study notes
Ella Jeffries / beckershospitalreview - An implanted radiation device has improved tumor control and overall survival compared with standard radiation therapy in patients with newly diagnosed operable brain metastases, according to phase 3 clinical trial data presented May 30 at the American So…
AI Summary: Clinical trial data show an implanted "tile" radiation device placed at resection sites lowers local recurrence risk for patients with brain metastases. The approach provides a targeted, intraoperative boost that shortens treatment timelines — and gives surgeons one more tool to argue they cured something before the tumor disagreed.
Related Stories
SBRT extends progression‑free survival in oligometastatic breast cancer / 7 wks
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 3 months
First‑in‑human glioblastoma immunotherapy yields promising PFS benefit / 9 hrs
Multi‑antigen T cells show early activity in pediatric brain cancers / 7 days
First‑in‑human IL‑2 cytokine factory trial shows early promise in ovarian cancer / 1 month
Personalized glioblastoma vaccine shows early promise in trials / 1 month
Small study reports 100% one‑year survival after lung transplant / 20 hrs
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Medicare Advantage (not listed), Reproductive Health, Trump Administration, None and look for the RSS link.
StackHealth Time Machine